semaglutide stock Type 2 diabetes drug improves weight loss, blood sugar in certain Type 1 patients with obesity NVO Stock: Should You Buy
Description
Both GLP-1/IgG-Fc and Ex4/IgG-Fc effectively reduced fed blood glucose levels in treated mice and ameliorated diabetes symptoms, where as control IgG-Fc had no effect
It is a major therapeutic target for type 2 diabetes and obesity
Read Does Where You Inject Your GLP-1 Shot Matter
New AI-based research showed there may be some side effects from taking a GLP-1 that are being missed in clinical trials.
We looked at this in 333,000 people
PlexusDx offers dual-compound GLP-1 formulations designed for personalized weight management
